The Oncology Institute(TOI) - 2025 Q4 - Annual Report
The Oncology InstituteThe Oncology Institute(US:TOI)2026-03-12 20:56
Transcript

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number 001-39248 (I.R.S. Employer Identification No.) 18000 Studebaker Rd, Suite 800 Cerritos, California 90703 (Address of Principa ...